COV — CLEO Diagnostics Balance Sheet
0.000.00%
Last trade - 00:00- AU$48.19m
- AU$41.73m
- AU$1.18m
Annual balance sheet for CLEO Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 0.043 | 0.24 | 9.37 | 6.46 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0.001 | 0.032 | 0.057 | 0.071 |
| Prepaid Expenses | ||||
| Total Current Assets | 0.044 | 0.58 | 9.44 | 6.55 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | — | 0.038 | 0.032 | 0.033 |
| Net Intangible Assets | ||||
| Total Assets | 0.244 | 1.08 | 9.88 | 6.94 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.286 | 2.02 | 0.486 | 1.1 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 0.286 | 2.02 | 0.486 | 1.1 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| ESOP Debt Guarantee | ||||
| Other Equity | ||||
| Total Equity | -0.042 | -0.943 | 9.39 | 5.83 |
| Total Liabilities & Shareholders' Equity | 0.244 | 1.08 | 9.88 | 6.94 |
| Total Common Shares Outstanding |